RNA-binding proteins in cancer: old players and new actors

B Pereira, M Billaud, R Almeida - Trends in cancer, 2017 - cell.com
RNA-binding proteins (RBPs) are key players in post-transcriptional events. The
combination of versatility of their RNA-binding domains with structural flexibility enables …

Post-transcriptional regulatory functions of mammalian pumilio proteins

AC Goldstrohm, TMT Hall, KM McKenney - TRENDS in Genetics, 2018 - cell.com
Mammalian Pumilio proteins, PUM1 and PUM2, are members of the PUF family of sequence-
specific RNA-binding proteins. In this review, we explore their mechanisms, regulatory …

[HTML][HTML] Programmable RNA tracking in live cells with CRISPR/Cas9

DA Nelles, MY Fang, MR O'Connell, JL Xu… - Cell, 2016 - cell.com
RNA-programmed genome editing using CRISPR/Cas9 from Streptococcus pyogenes has
enabled rapid and accessible alteration of specific genomic loci in many organisms. A …

Efficient, specific, and combinatorial control of endogenous exon splicing with dCasRx-RBM25

JD Li, M Taipale, BJ Blencowe - Molecular Cell, 2024 - cell.com
Efficient targeted control of splicing is a major goal of functional genomics and therapeutic
applications. Guide (g) RNA-directed, deactivated (d) Cas CRISPR enzymes fused to …

RNA splicing dysregulation and the hallmarks of cancer

RK Bradley, O Anczuków - Nature Reviews Cancer, 2023 - nature.com
Dysregulated RNA splicing is a molecular feature that characterizes almost all tumour types.
Cancer-associated splicing alterations arise from both recurrent mutations and altered …

[HTML][HTML] SR proteins collaborate with 7SK and promoter-associated nascent RNA to release paused polymerase

X Ji, Y Zhou, S Pandit, J Huang, H Li, CY Lin, R Xiao… - Cell, 2013 - cell.com
RNAP II is frequently paused near gene promoters in mammals, and its transition to
productive elongation requires active recruitment of P-TEFb, a cyclin-dependent kinase for …

Nuclear Aurora kinase A switches m6A reader YTHDC1 to enhance an oncogenic RNA splicing of tumor suppressor RBM4

SS Li, YF Qi, JC Yu, YC Hao, B He, MJ Zhang… - … and Targeted Therapy, 2022 - nature.com
Aberrant RNA splicing produces alternative isoforms of genes to facilitate tumor progression,
yet how this process is regulated by oncogenic signal remains largely unknown. Here, we …

Splicing at the phase-separated nuclear speckle interface: a model

SE Liao, O Regev - Nucleic acids research, 2021 - academic.oup.com
Phase-separated membraneless bodies play important roles in nucleic acid biology. While
current models for the roles of phase separation largely focus on the compartmentalization …

The splicing factor RBM4 controls apoptosis, proliferation, and migration to suppress tumor progression

Y Wang, D Chen, H Qian, YS Tsai, S Shao, Q Liu… - Cancer cell, 2014 - cell.com
Splicing dysregulation is one of the molecular hallmarks of cancer. However, the underlying
molecular mechanisms remain poorly defined. Here we report that the splicing factor RBM4 …

Antagonistic regulation of mRNA expression and splicing by CELF and MBNL proteins

ET Wang, AJ Ward, JM Cherone, J Giudice… - Genome …, 2015 - genome.cshlp.org
RNA binding proteins of the conserved CUGBP1, Elav-like factor (CELF) family contribute to
heart and skeletal muscle development and are implicated in myotonic dystrophy (DM). To …